Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKinsey
Dow
Colorcon
Merck

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Mibefradil

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Mibefradil: Sponsors, patents, clinical trial progress

Mibefradil is an investigational drug.

There have been 5 clinical trials for Mibefradil. The most recent clinical trial was a Phase 1 trial, which was initiated on May 28th 2018.

The most common disease conditions in clinical trials are Glioma, Central Nervous System Neoplasms, and Dyslipidemias. The leading clinical trial sponsors are Cavion LLC, Instituto Nacional de Salud Publica, Mexico, and National Cancer Institute (NCI).

There are nine hundred and seventy US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Mibefradil
TitleSponsorPhase
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican PopulationInstituto Nacional de Salud Publica, MexicoPhase 3
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican PopulationLaboratorios Grossman, S.A.Phase 3
TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBMYale UniversityPhase 1

See all Mibefradil clinical trials

Clinical Trial Summary for Mibefradil

Top disease conditions for Mibefradil
Top clinical trial sponsors for Mibefradil

See all Mibefradil clinical trials

US Patents for Mibefradil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mibefradil   See Pricing Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA)   See Pricing
Mibefradil   See Pricing Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   See Pricing
Mibefradil   See Pricing Synthetic linear apelin mimetics for the treatment of heart failure NOVARTIS AG (Basel, CH)   See Pricing
Mibefradil   See Pricing Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Mibefradil

Drugname Country Document Number Estimated Expiration Related US Patent
Mibefradil European Patent Office 2981556 2033-04-02   See Pricing
Mibefradil World Intellectual Property Organization (WIPO) 2014165513 2033-04-02   See Pricing
Mibefradil Australia 2015210983 2034-01-30   See Pricing
Mibefradil Canada 2934936 2034-01-30   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Merck
Colorcon
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.